Bpc 157 4 Mg. How To Reconstitute With Water

Laboratory Protocol: Reconstituting BPC-157 4 mg with Water

To reconstitute a standard 4 mg vial of BPC-157 for laboratory research, introduce 2.0 mL of bacteriostatic water under sterile conditions to yield a final concentration of 2.0 mg/mL (2000 µg/mL). Gently swirl the vial without vortexing until the lyophilized cake fully dissolves, and store the reconstituted solution between 2°C and 8°C.

Precision in volumetric reconstitution dictates the accuracy of subsequent serial dilutions and assay dosing. When preparing high-purity BPC-157 4 mg, researchers must select a diluent volume tailored to their specific laboratory protocol. Adding 1.0 mL of reconstituting fluid yields a concentration of 4.0 mg/mL (4000 µg/mL), whereas adding 4.0 mL yields a concentration of 1.0 mg/mL (1000 µg/mL). For most automated microplate pipetting systems and preclinical animal models, a 2.0 mL addition provides an optimal balance between volumetric precision and liquid handling convenience.

Aseptic technique must be maintained throughout the reconstitution process. Swab the rubber septum of the vial with 70% isopropyl alcohol and allow it to air-dry completely under a laminar flow hood. Draw the predetermined volume of sterile bacteriostatic water using a precision laboratory syringe. Inject the diluent slowly along the inner glass wall of the vial rather than directly onto the peptide cake. Direct high-pressure fluid impact can cause structural shearing of delicate peptide chains. Allow the fluid to saturate the lyophilized powder naturally before gently rotating the vial between your palms. Never shake or vortex the vial, as mechanical agitation can induce protein denaturation and aggregation.

Chemical Structure and Molecular Profile of BPC-157

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a naturally occurring protein fragment isolated from human gastric juice. Comprising 15 amino acids, its primary sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular formula of C62H98N16O22 and a molecular mass of approximately 1419.5 Da. Unlike many linear peptides that exhibit rapid degradation in aqueous environments, BPC-157 features exceptional structural stability owing to its specific proline-rich sequence configuration.

In physical form, high-purity BPC-157 presents as a dense, white lyophilized powder. The lyophilizate includes stabilizing matrix components (typically mannitol or trehalose) to preserve tertiary structure during freeze-drying. When stored as an anhydrous solid at -20°C, the peptide maintains chemical stability for extended periods. Understanding the chemical structure of synthetic peptides within our PX1 research peptide catalog allows researchers to predict solubility characteristics, ionic interactions in buffer solutions, and degradation pathways under varying pH and thermal conditions.

Preclinical Mechanisms: Angiogenesis and Cellular Migration

Preclinical investigations demonstrate that BPC-157 operates primarily through the upregulation of angiogenic signaling pathways and the acceleration of cellular migration to damaged tissue loci. In vitro assays evaluating endothelial cell activity show that BPC-157 increases expression of Vascular Endothelial Growth Factor (VEGF) and activates Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). This internal signaling cascade promotes capillary lumen formation, endothelial cell proliferation, and functional neovascularization within ischemic or injured tissue microenvironments.

Furthermore, cell migration studies demonstrate that BPC-157 promotes the phosphorylation of Focal Adhesion Kinase (FAK) and paxillin. These key signaling proteins govern cell attachment, cytoskeletal rearrangement, and directional cell motility. By modulating the FAK-paxillin pathway, BPC-157 enhances the migration velocity of fibroblasts and tendon-derived cells toward wounded areas. Researchers investigating structural repair pathways can read more in our detailed bpc-157 mechanism of action guide.

Tendon, Ligament, and Skeletal Muscle Repair Preclinical Data

A substantial body of literature examines BPC-157 across rodent models of musculoskeletal trauma. In rat models of Achilles tendon transection, administration of BPC-157 significantly accelerated functional tendon recovery, increased load-to-failure mechanical thresholds, and enhanced collagen fiber alignment compared to control groups. Histological evaluations revealed increased fibroblast density and elevated expression of type I collagen over type III collagen, indicating structural remodeling rather than unorganized scar tissue formation.

Similarly, preclinical studies utilizing skeletal muscle crush injuries and ligament tear models reported accelerated structural regeneration. In vitro studies using cultured tendon explants demonstrate that exposure to BPC-157 increases growth hormone receptor (GHR) expression, suggesting a synergistic mechanism with local endogenous growth factors. These findings highlight BPC-157 as a critical reference compound for assays focused on extracellular matrix synthesis, tenocyte viability, and structural tissue repair.

Gastrointestinal Mucosal Integrity and Cytoprotection Studies

Because BPC-157 was originally identified within gastric secretion fractions, extensive preclinical research evaluates its organoprotective and cytoprotective properties across the gastrointestinal tract. In rodent models of indomethacin- or ethanol-induced gastric lesions, pre- or post-treatment with BPC-157 significantly attenuated mucosal erosion depth, reduced inflammatory cytokine infiltration (such as TNF-alpha and IL-6), and preserved mucosal wall thickness.

The molecular mechanism underlying gastrointestinal protection involves cross-talk with the endogenous nitric oxide (NO) system. In vitro data indicate that BPC-157 counteracts both excessive NO production induced by inducible nitric oxide synthase (iNOS) during acute inflammation and deficient NO production stemming from endothelial nitric oxide synthase (eNOS) inhibition. This dual-regulatory capacity helps maintain microvascular perfusion in the gut mucosa, preserving epithelial barrier integrity against ulcerative agents and oxidative stress.

Comparative Analysis: BPC-157 vs. TB-500 and GHK-Cu

When designing tissue regeneration assays, researchers frequently evaluate BPC-157 alongside other cell-modifying peptides to determine relative efficacy and pathway specificity. While BPC-157 accelerates repair via localized VEGFR2 and FAK pathway activation, TB-500 (Thymosin Beta-4 fragment) functions primarily through actin monomer sequestration, promoting systemic cell migration, angiogenesis, and anti-inflammatory signaling across broader tissue types. Concurrently, GHK-Cu copper peptide focuses on extracellular matrix remodeling by upregulating collagen, elastin, and glycosaminoglycan synthesis while modulating metalloproteinase activity.

Comparing these distinct mechanisms allows research teams to select the appropriate peptide model for specific tissue types. For instance, while BPC-157 is widely selected for dense connective tissue and mucosal membrane models, TB-500 is often selected for systemic cell motility studies, and GHK-Cu for dermal remodeling assays. Comprehensive comparative data across these compounds can be reviewed in our bpc-157 vs tb-500 research comparison in the PX1 Research Library hub.

Diluent Selection: Bacteriostatic Water vs. Sterile Saline

Selecting the correct solvent for peptide reconstitution is critical for preserving peptide stability and preventing bacterial contamination during multi-dose experimental schedules. Bacteriostatic water—sterile water containing 0.9% benzyl alcohol—is the gold standard for reconstituting laboratory peptides intended for repeated withdrawal over multiple days or weeks. The benzyl alcohol preservative inhibits microbial growth, allowing reconstituted solutions to remain stable for up to 28 days when stored at 2°C to 8°C.

Conversely, sterile 0.9% sodium chloride (saline) or plain sterile water for injection lacks antimicrobial agents. Vials reconstituted with plain sterile water must be used immediately in a single assay run and discarded, as ambient bacterial introduction during needle entry rapidly degrades peptide integrity. For long-term cell culture or enzymatic assays sensitive to benzyl alcohol, researchers may reconstitute in sterile PBS (phosphate-buffered saline), provided the solution is aliquoted and frozen immediately under sterile conditions.

Quality Verification: Analytical Testing and Standards

Experimental reproducibility relies entirely on compound purity, identity verification, and freedom from bacterial contamination. PX1 Research subjects every lot of BPC-157 to rigorous analytical quality control conducted by independent ISO 17025 accredited laboratories. Primary purity verification is performed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a purity threshold equal to or exceeding 99.0%. Mass identity is confirmed through Electrospray Ionization Mass Spectrometry (ESI-MS), matching the observed molecular mass precisely to theoretical values.

In addition to purity and identity, endotoxin quantification is mandatory for valid cellular and animal research. High endotoxin levels induce non-specific inflammatory responses in vitro and toxic shock pathways in vivo, corrupting experimental data. PX1 Research enforces strict Limulus Amebocyte Lysate (LAL) testing, guaranteeing endotoxin levels under <0.1 EU/mg. Every product shipment includes a batch-specific Certificate of Analysis (COA) cross-referencing lot numbers, synthesis origin in GMP-compliant USA facilities, and complete spectral data. Laboratories establishing recurring procurement protocols can access dedicated pricing via our wholesale laboratory account portal.

Handling, Storage, and Degradation Mitigation

Lyophilized BPC-157 4 mg vials should be stored upon arrival at -20°C in a desiccated freezer compartment protected from light exposure. In an anhydrous state at sub-zero temperatures, the peptide remains stable for up to 24 months. Avoid frequent fluctuations in storage temperature; repeated thermal cycling leads to moisture condensation within the vial, triggering chemical hydrolytic cleavage of peptide bonds.

Once reconstituted with bacteriostatic water, the working solution must be kept refrigerated between 2°C and 8°C. Protect the solution from UV light by storing vials in aluminum foil or amber containers. Avoid repeated freeze-thaw cycles of reconstituted liquid solutions, as the formation of ice crystals causes mechanical shear stress that breaks peptide chains. If long-term liquid storage is necessary, aliquot the reconstituted solution into single-use microcentrifuge tubes immediately after preparation, freeze at -80°C, and thaw a single aliquot only when ready to perform an assay. For complete handling guidelines, consult our peptide storage standards.